The idiopathic CD4+ lymphocytopenia market is estimated to be valued at USD 130.4 Mn in 2025 and is expected to reach USD 223.5 Mn by 2032, growing at a compound annual growth rate (CAGR) of 8.00% from 2025 to 2032. https://www.zupyak.com/p/4609125/t/idiopathic-cd4-lymphocytopenia-market-growth-and-forecast-analysis